CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy

By sjmartinez • April 1, 2025

Marshalek JP, Qing X, Tomassetti S. CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World J Oncol. 2025 Apr;16(2):235-238. doi: 10.14740/wjon2534. Epub 2025 Mar 13. PMID: 40162108; PMCID: PMC11954608.

Tags: Harbor UCLA, Hematology/Oncology, Publications

Related Posts

Prediction of the Statin responders with radiomics

Lee SE, Hong Y, Jung J, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb[...]

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes

Narasaki Y, Kalantar-Zadeh K, Zisman-Ilani Y, Klonoff DC, Kovesdy CP, Li Z, Jin A, Crowley S, M Belcher J, Gee P, Gin GE, Jordan M,[...]

Deep learning-based CT-derived vertebral bone mineral density and metformin therapy: a longitudinal study in the Multi-Ethnic Study of Atherosclerosis

Momtazmanesh S, Hathaway QA, Jannatdoust P, Ghotbi E, Bancks MP, Bluemke DA, Barr RG, Smith BM, Post WS, Budoff MJ, Lima JAC, Demehri S. Deep[...]